SMT201300116B - Procedimenti e intermedi per la preparazione di uninibitore macrociclico di proteasi di hcv - Google Patents

Procedimenti e intermedi per la preparazione di uninibitore macrociclico di proteasi di hcv

Info

Publication number: SMT201300116B
Authority: SM; San Marino
Prior art keywords: intermediates; preparation; hcv; procedures; protease inhibitor
Prior art date: 2008-12-23

Application number

SM201300116T

Other languages

English (en)

Inventor

Andras Horvath

Dominic John Ormerod

Dominique Paul Michel Depre

Veronique Cerpentier

Original Assignee

Janssen Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-12-23

Filing date

2013-10-10

Publication date

2013-11-08

2013-10-10 Application filed by Janssen Pharmaceuticals Inc filed Critical Janssen Pharmaceuticals Inc

2013-11-08 Publication of SMT201300116B publication Critical patent/SMT201300116B/it

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/475—Preparation of carboxylic acid esters by splitting of carbon-to-carbon bonds and redistribution, e.g. disproportionation or migration of groups between different molecules
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Virology (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Furan Compounds (AREA)
Peptides Or Proteins (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

SM201300116T 2008-12-23 2013-10-10 Procedimenti e intermedi per la preparazione di uninibitore macrociclico di proteasi di hcv SMT201300116B (it)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP08172691		2008-12-23
PCT/EP2009/067715 WO2010072742A1 (en)	2008-12-23	2009-12-22	Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv

Publications (1)

Publication Number	Publication Date
SMT201300116B true SMT201300116B (it)	2013-11-08

Family

ID=40548041

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SM201300116T SMT201300116B (it)	2008-12-23	2013-10-10	Procedimenti e intermedi per la preparazione di uninibitore macrociclico di proteasi di hcv

Country Status (23)

Country	Link
US (2)	US8927722B2 (it)
EP (1)	EP2382198B1 (it)
JP (1)	JP5687631B2 (it)
KR (1)	KR101734507B1 (it)
CN (1)	CN102264715B (it)
AR (1)	AR074863A1 (it)
AU (1)	AU2009331530B2 (it)
BR (1)	BRPI0923393B1 (it)
CA (1)	CA2745565C (it)
CY (1)	CY1114488T1 (it)
DK (1)	DK2382198T3 (it)
ES (1)	ES2429013T3 (it)
HK (1)	HK1164839A1 (it)
HR (1)	HRP20130906T1 (it)
IL (1)	IL213246A (it)
MX (1)	MX2011006764A (it)
PL (1)	PL2382198T3 (it)
PT (1)	PT2382198E (it)
RU (1)	RU2016120007A (it)
SI (1)	SI2382198T1 (it)
SM (1)	SMT201300116B (it)
TW (1)	TWI461424B (it)
WO (1)	WO2010072742A1 (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2016120007A (ru)	2008-12-23	2018-11-13	Орто-Макнейл-Янссен Фармасьютикалз, Инк	Способы и промежуточные соединения для получения макроциклического ингибитора протеазы вируса гепатита c
BR112014006984A2 (pt) *	2011-09-22	2017-04-04	Janssen Pharmaceuticals Inc	processos e intermediários para a preparação de um inibidor macrocíclico de proteases do hcv
CA2848377A1 (en) *	2011-10-28	2013-05-02	Janssen Pharmaceuticals, Inc.	Improved process for preparing an intermediate of the macrocyclic protease inhibitor tmc 435
CN103387509B (zh) *	2012-05-11	2016-06-08	重庆博腾制药科技股份有限公司	一种hcv蛋白酶抑制剂中间体的制备方法
BR112014030649A2 (pt)	2012-06-08	2017-06-27	Gilead Sciences Inc	inibidores macrocíclicos da flaviviridae vírus
WO2013185103A1 (en)	2012-06-08	2013-12-12	Gilead Sciences, Inc.	Macrocyclic inhibitors of flaviviridae viruses
AR091279A1 (es)	2012-06-08	2015-01-21	Gilead Sciences Inc	Inhibidores macrociclicos de virus flaviviridae
UA119315C2 (uk)	2012-07-03	2019-06-10	Гіліад Фармассет Елелсі	Інгібітори вірусу гепатиту с
WO2014145095A1 (en)	2013-03-15	2014-09-18	Gilead Sciences, Inc.	Macrocyclic and bicyclic inhibitors of hepatitis c virus
CN105308043B (zh) *	2014-05-29	2018-01-30	杭州普晒医药科技有限公司	丙型肝炎药物的晶型及其制备方法、其药物组合物和用途
MA41812A (fr)	2015-03-27	2018-01-30	Janssen Pharmaceuticals Inc	Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhc

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL8300536A (nl) *	1983-02-14	1984-09-03	Oce Andeno Bv	Optisch actief alfa-azido-p-hydroxyfenylazijnzuur en zijn zouten alsmede de bereiding daarvan.
JPS6124539A (ja) *	1984-07-11	1986-02-03	Sagami Chem Res Center	光学活性（ｒ）−２，５，１２−トリヒドロキシ−１，２，３，４−テトラヒドロナフタセン−６，１１−ジオン−２−カルボン酸の取得方法
JP4218040B2 (ja) *	1997-12-26	2009-02-04	曽田香料株式会社	有機酸とアミンの複合塩の製造法
JP3844112B2 (ja)	2000-08-23	2006-11-08	高砂香料工業株式会社	３，５，６−トリヒドロキシヘキサン酸アンモニウム塩誘導体、及びその製造方法
NZ548739A (en)	2004-01-30	2010-10-29	Medivir Ab	HCV NS-3 Serine protease inhibitors
CN101146794A (zh)	2005-01-21	2008-03-19	阿斯泰克斯治疗有限公司	用于抑制cdk和gsk的吡唑衍生物
PE20070211A1 (es) *	2005-07-29	2007-05-12	Medivir Ab	Compuestos macrociclicos como inhibidores del virus de hepatitis c
MY139988A (en) *	2005-07-29	2009-11-30	Tibotec Pharm Ltd	Macrocylic inhibitors of hepatitis c virus
PT2121674E (pt) *	2007-02-01	2010-09-03	Tibotec Pharm Ltd	Processos e intermediários para a preparação de um inibidor macrocíclico da protease do hcv
CN101627020B (zh) *	2007-02-08	2015-06-17	泰博特克药品有限公司	抑制hcv的大环苯基氨基甲酸酯
RU2016120007A (ru)	2008-12-23	2018-11-13	Орто-Макнейл-Янссен Фармасьютикалз, Инк	Способы и промежуточные соединения для получения макроциклического ингибитора протеазы вируса гепатита c

2009
- 2009-12-22 RU RU2016120007A patent/RU2016120007A/ru not_active Application Discontinuation
- 2009-12-22 SI SI200930731T patent/SI2382198T1/sl unknown
- 2009-12-22 MX MX2011006764A patent/MX2011006764A/es active IP Right Grant
- 2009-12-22 CN CN200980152851.5A patent/CN102264715B/zh not_active Expired - Fee Related
- 2009-12-22 DK DK09801447.5T patent/DK2382198T3/da active
- 2009-12-22 BR BRPI0923393-8A patent/BRPI0923393B1/pt not_active IP Right Cessation
- 2009-12-22 US US13/141,715 patent/US8927722B2/en not_active Expired - Fee Related
- 2009-12-22 TW TW98144049A patent/TWI461424B/zh not_active IP Right Cessation
- 2009-12-22 CA CA2745565A patent/CA2745565C/en not_active Expired - Fee Related
- 2009-12-22 KR KR1020117017333A patent/KR101734507B1/ko active IP Right Grant
- 2009-12-22 ES ES09801447T patent/ES2429013T3/es active Active
- 2009-12-22 AU AU2009331530A patent/AU2009331530B2/en not_active Ceased
- 2009-12-22 JP JP2011541509A patent/JP5687631B2/ja not_active Expired - Fee Related
- 2009-12-22 WO PCT/EP2009/067715 patent/WO2010072742A1/en active Application Filing
- 2009-12-22 EP EP09801447.5A patent/EP2382198B1/en active Active
- 2009-12-22 PT PT09801447T patent/PT2382198E/pt unknown
- 2009-12-22 AR ARP090105059 patent/AR074863A1/es unknown
- 2009-12-22 PL PL09801447T patent/PL2382198T3/pl unknown
2011
- 2011-05-31 IL IL213246A patent/IL213246A/en not_active IP Right Cessation
2012
- 2012-05-29 HK HK12105238.7A patent/HK1164839A1/zh not_active IP Right Cessation
2013
- 2013-09-24 HR HRP20130906AT patent/HRP20130906T1/hr unknown
- 2013-10-10 SM SM201300116T patent/SMT201300116B/it unknown
- 2013-10-10 CY CY20131100890T patent/CY1114488T1/el unknown
2014
- 2014-11-25 US US14/552,550 patent/US9115077B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
RU2011130895A (ru)	2013-01-27
US20110257403A1 (en)	2011-10-20
HK1164839A1 (zh)	2012-09-28
BRPI0923393B1 (pt)	2018-06-19
EP2382198B1 (en)	2013-07-10
WO2010072742A1 (en)	2010-07-01
RU2016120007A (ru)	2018-11-13
AR074863A1 (es)	2011-02-16
AU2009331530B2 (en)	2015-04-09
TW201033205A (en)	2010-09-16
DK2382198T3 (da)	2013-09-30
HRP20130906T1 (hr)	2013-10-25
AU2009331530A1 (en)	2011-06-23
IL213246A (en)	2017-10-31
PT2382198E (pt)	2013-10-01
JP5687631B2 (ja)	2015-03-18
KR101734507B1 (ko)	2017-05-11
US8927722B2 (en)	2015-01-06
CN102264715A (zh)	2011-11-30
MX2011006764A (es)	2011-08-03
PL2382198T3 (pl)	2013-11-29
BRPI0923393A2 (pt)	2015-07-28
ES2429013T3 (es)	2013-11-12
SI2382198T1 (sl)	2013-11-29
TWI461424B (zh)	2014-11-21
KR20110099048A (ko)	2011-09-05
CA2745565C (en)	2017-03-07
US20150080577A1 (en)	2015-03-19
CA2745565A1 (en)	2010-07-01
JP2012513381A (ja)	2012-06-14
CY1114488T1 (el)	2016-10-05
CN102264715B (zh)	2015-12-02
US9115077B2 (en)	2015-08-25
EP2382198A1 (en)	2011-11-02
IL213246A0 (en)	2011-07-31

Publication	Publication Date	Title
SMT201300116B (it)	2013-11-08	Procedimenti e intermedi per la preparazione di uninibitore macrociclico di proteasi di hcv
CY2017033I2 (el)	2018-04-04	Αναστολεις πρωτεασης σερινης hcv λαμβανομενοι απο μακροκυκλικη προλινη
NI201100170A (es)	2012-02-21	Inhibidores de epoxicetonas proteasa de tripéptidos cristalinos
MX2011011272A (es)	2011-11-04	Procesos e intermediarios.
PH12013500365A1 (en)	2014-09-08	Anti-infective agents and uses thereof
BRPI0822775A2 (pt)	2015-06-30	Método de obtenção de uma proteína heteróloga, purificada, biologicamente ativa.
ES2386734T8 (es)	2012-09-21	Ácidos fenoxiacéticos como activadores de PPAR-delta.
WO2010111436A3 (en)	2011-04-07	Antiviral compounds and uses thereof
WO2012136383A8 (en)	2013-01-17	Preparation of sitagliptin intermediates
UA111827C2 (uk)	2016-06-24	Спосіб отримання інгенол-3-ангелату
EP2139883A4 (en)	2011-06-22	HIV-1 protease inhibitor
EA201270280A1 (ru)	2013-01-30	Соединения пиримидина в качестве ингибиторов при лечении туберкулеза
EP2245015A4 (en)	2012-05-30	DIFLUORATED TRIPEPTIDES AS INHIBITORS OF HCV SERINE PROTEASE
MY155330A (en)	2015-09-30	Methods for salt production
AP2013006690A0 (en)	2013-01-31	Process for preparation of HIV protease inhibitors
WO2012137180A3 (en)	2013-02-28	Biomarkers of immunotherapy efficacy
UA106886C2 (uk)	2014-10-27	Спосіб одержання 1-бензил-3-гідроксиметил-1h-індазолу і його похідних та проміжні сполуки магнію
EP2291079A4 (en)	2011-06-22	FORMULATIONS FOR CATHEPSIN K HEMMER
BRPI0822347A2 (pt)	2019-09-24	método de produção de proteínas ou peptídeos heterólogos.
CL2014001043A1 (es)	2014-07-25	Procedimiento para preparar un compuesto intermediario en la ruta de sintesis de tmc 435, inhibidor de proteasa, útil en el tratamiento de la hepatitis c.
ITRM20080037A1 (it)	2009-07-24	Procedimento per la ultrapurificazione di alginati.
IT1397023B1 (it)	2012-12-20	Composizioni comprendenti amminoacidi, per il trattamento della broncopneumopatia cronica ostruttiva
EA200870236A1 (ru)	2009-02-27	Моногидрат римонабанта, способ его получения и фармацевтические композиции на его основе
IL211266A (en)	2016-04-21	Process for adding thiols to alpha, beta-unsaturated beta compounds of sulfonyl or sulfonyl
EA201270223A1 (ru)	2012-07-30	ЭНАНТИО- И СТЕРЕОСПЕЦИФИЧЕСКИЕ СИНТЕЗЫ β-АМИНО-α-ГИДРОКСИАМИДОВ